MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fphar.2020.596467

Медицинская библиотека · Frontiers in pharmacology · 2020

Impact of Opioid Consumption in Patients With Functional Gastrointestinal Disorders.

Melchior Chloé, Desprez Charlotte, Wuestenberghs Fabien, Leroi Anne-Marie, Lemaire Antoine, Goucerol Guillaume

СтатьяПеревод пока не подготовлен

Аннотация

Objective

We aimed to determine the burden of opioid consumption in a cohort of patients with functional gastrointestinal disorders.

Methods

All patients diagnosed with functional gastrointestinal disorders and referred to our university hospital were evaluated from 2013 to the beginning of 2019. Irritable bowel syndrome and functional dyspepsia diagnoses were determined according to Rome criteria and severity according to irritable bowel syndrome severity scoring system. Vomiting was quantified using a 5-point Likert scale, and constipation severity was measured using the Knowles-Eccersley-Scott-Symptom questionnaires. Quality of life was quantified by the GastroIntestinal Quality of Life Index. Patients were categorized as being treated on a chronic basis with either tramadol, step II opioids, step III opioids or as being opioid-free.

Results

2933 consecutive patients were included. In our cohort, 12.5% had only irritable bowel syndrome, 39.3% had only functional dyspepsia, 24.9% had a combination of both, and 23.4% had other functional gastrointestinal disorders. Among them, the consumption of tramadol, step II (tramadol excluded) and step III opioids was 1.8, 1.3 and 0.3 % respectively in 2013 and 4.3, 3.4 and 1.9% in 2018 (p < 0.03). Opioid consumption was associated with increased vomiting (p = 0.0168), constipation (p < 0.0001), symptom severity (p < 0.001), more altered quality of life (p < 0.0001) and higher depression score (p = 0.0045).

Conclusion

In functional gastrointestinal disorders, opioid consumption has increased in the last years and is associated with more GI symptoms (vomiting, constipation and GI severity), higher depression and more altered quality of life.

Для цитирования: Melchior Chloé, Desprez Charlotte, Wuestenberghs Fabien, Leroi Anne-Marie, Lemaire Antoine, Goucerol Guillaume. Impact of Opioid Consumption in Patients With Functional Gastrointestinal Disorders.. Frontiers in pharmacology. 2020. DOI: 10.3389/fphar.2020.596467.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.